Evidence map›Paper›PMID 34831253›Full record

ReviewCells2021

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues.

Rajan Singh, Albert Barrios, Golnaz Dirakvand, Shehla Pervin

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Cold exposure-inducedActa pharmaceutica Sinica. B · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Frontiers in pharmacology · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Rajan SinghDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0002-6409-4910
Albert BarriosDivision of Endocrinology and Metabolism, Charles R Drew University of Medicine and Science, Los Angeles, CA 90059, USA.ORCID 0000-0002-8577-6566
Golnaz DirakvandDepartment of Biology, California State University, Dominguez Hills, Los Angeles, CA 90747, USA.
Shehla PervinDepartment of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.
California State University, Dominguez Hills · USBrigham and Women's Hospital · USUniversity of California, Los Angeles · US

Funding

Sustaining Faculty Development & Community EngagementS21MD000103 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CARLISLE, DAVID M · 2001 to 2015
$73.9M
Workshop for Junior Biostatisticians in Health ResearchU54MD007598 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI Yong Wu · 2012 to 2026
$60.0M
Beige Adipocytes and African American Breast TumorsSC1CA232319 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI PERVIN, SHEHLA · 2018 to 2021
$1.4M
Follistatin promotes browning and influences energy metabolismSC1AG049682 · NIA · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI SINGH, RAJAN · 2014 to 2017
$1.1M
NCI NIH HHS SC1 CA232319NIA NIH HHS SC1 AG049682NIMHD NIH HHS S21 MD000103NIMHD NIH HHS U54 MD007598TRDRP T31IP1551
6 · The paper itself

Abstract

Obesity-associated metabolic abnormalities comprise a cluster of conditions including dyslipidemia, insulin resistance, diabetes and cardiovascular diseases that has affected more than 650 million people all over the globe. Obesity results from the accumulation of white adipose tissues mainly due to the chronic imbalance of energy intake and energy expenditure. A variety of approaches to treat or prevent obesity, including lifestyle interventions, surgical weight loss procedures and pharmacological approaches to reduce energy intake and increase energy expenditure have failed to substantially decrease the prevalence of obesity. Brown adipose tissue (BAT), the primary source of thermogenesis in infants and small mammals may represent a promising therapeutic target to treat obesity by promoting energy expenditure through non-shivering thermogenesis mediated by mitochondrial uncoupling protein 1 (UCP1). Since the confirmation of functional BAT in adult humans by several groups, approximately a decade ago, and its association with a favorable metabolic phenotype, intense interest on the significance of BAT in adult human physiology and metabolic health has emerged within the scientific community to explore its therapeutic potential for the treatment of obesity and metabolic diseases. A substantially decreased BAT activity in individuals with obesity indicates a role for BAT in the setting of human obesity. On the other hand, BAT mass and its prevalence correlate with lower body mass index (BMI), decreased age and lower glucose levels, leading to a lower incidence of cardio-metabolic diseases. The increased cold exposure in adult humans with undetectable BAT was associated with decreased body fat mass and increased insulin sensitivity. A deeper understanding of the role of BAT in human metabolic health and its interrelationship with body fat distribution and deciphering proper strategies to increase energy expenditure, by either increasing functional BAT mass or inducing white adipose browning, holds the promise for possible therapeutic avenues for the treatment of obesity and associated metabolic disorders.

Indexed as

HealthAdipose Tissue, BrownAnimalsExerciseFemaleGene Expression ProfilingHumansMaleMicroRNAsObesitySex CharacteristicsMicroRNAsadipose browningbeige adipose tissuebeta-adrenergic receptorbrown adipose tissuecold exposureenergy expendituremicro-RNAobesityuncoupling protein-1

Identifiers

PMID34831253
PMCPMC8616549
OpenAlexW3212543589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.